ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)

Similar documents
EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas

A systematic review of validated methods for identifying atrial fibrillation using administrative data

Prevalence (%) Table S4 Prevalence of AF in women and men, age- specific Study name/country Study population Study period Age group

Characteristics of Hospitalized Patients with Atrial Fibrillation in Taiwan: A Nationwide Observation

Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly

Table S10 Mortality Study

Atrial fibrillation (AF) persists as a growing health concern

Black US residents experience ischemic stroke at a

The Clinical Utility of Normal Findings on Non-Invasive Cardiac Assessment in the Prediction of Atrial Fibrillation

JAMA, January 11, 2012 Vol 307, No. 2

Supplementary Online Content

SUPPLEMENTARY INFORMATION

Management of Atrial Fibrillation. Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation

Systematic Review of Dementia Prevalence and Incidence of Dementia in United States Race/Ethnic Populations. Search. Data Base.

Prof. Fiorenzo Gaita

Atrial Fibrillation & Acute Stroke

Asymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco

Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Atrial fibrillation is a potent risk factor for ischemic

More than 3 million Americans are presently living with

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD

NeuroPI Case Study: Anticoagulant Therapy

Journal of the American College of Cardiology Vol. 43, No. 3, by the American College of Cardiology Foundation ISSN /04/$30.

Racial and Ethnic Inequalities in Dementia: What Can We Learn from a Healthcare System Cohort?

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?

Subclinical AF: Implications of device based episodes

ARIC Manuscript Proposal #2099. PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority:

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

DOACs for Atrial Fibrillation, Why Are So Many AF Patients NOT on Anticoagulation? David Garcia, MD April 2017

Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA

Get With The Guidelines - Stroke and Trends in New Jersey

Evaluate Risk of Stroke & Bleeding in AF Patients

ΑΣΥΜΠΤΩΜΑΤΙΚΗ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ

TOBACCO USE AND ETHNICITY

Systematic Review of Dementia Prevalence and Incidence of Dementiain United States Race/Ethnic Populations

Disparities in Transplantation Caution: Life is not fair.

Geographic disparities in stroke have been persistent over

Which Hospitals Treat Patients with the Most Severe Acute Ischemic Strokes? Implications for Hospital Mortality Reporting

Review of devices for early AF detection Nadya Hamedi Primary Care cardiovascular pharmacist Health innovation Network

Alcohol Users in Treatment

Racial and Socioeconomic Disparities in Appendicitis

ATRIAL FIBRILLATION AROUND THE WORLD/ CONTINENTAL PERSPECTIVES AND SPECIFICITIES: SOUTH AMERICA. LUIS AGUINAGA MD, PhD, FESC,FACC Argentina

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Chapter 6: Medicare Expenditures for CKD

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences?

Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

Weighing the risk of stroke vs the risk of bleeding: Which AF patients should be anticoagulated?

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

Advancing Stroke Systems of Care to Improve Outcomes Update on Target: Stroke Phase II

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

The Burden of Cardiovascular Disease in North Carolina. Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018

HealthStats HIDI JUNE 2014 MEN S HEALTH MONTH

Original Paper. Neuroepidemiology 2016;47:53 58 DOI: /

ARIC Manuscript Proposal # PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation,

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study

EHRA/EUROPACE 2011 Madrid, Spain June

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

I have nothing to disclose.

Changing Patient Base. A Knowledge to Practice Program

Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore

GERIATRICS CASE PRESENTATION

Heart Disease and Stroke Statistics 2018 At-a-Glance

Supplementary Online Content

Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010

Chapter 5: Acute Kidney Injury

How Should we Select Patients for Catheter Ablation? Douglas Esberg, MD, FHRS

ECTOPIC BEATS: HOW MANY COUNT?

» A new drug s trial

Bipolar Disorder and Schizophrenia Present Different Risks of Atrial fibrillation: A Nationwide Population-Based Analysis

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

Salt Lake County Annual Influenza Report Season Bureau of Epidemiology

Chapter 3: Morbidity and Mortality in Patients with CKD

Frontal QRS-T Angle and the Risk of Atrial Fibrillation in the Elderly

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012

Will Equity Be Achieved Through Health Care Reform?

Supplementary Online Content

Protocol Number K16. Version 1.2 September 29 th, Study promoted by Fondazione per il Tuo cuore - HCF Onlus

Health Disparities Research. Kyu Rhee, MD, MPP, FAAP, FACP Chief Public Health Officer Health Resources and Services Administration

A COhort of antithrombotic use and. atrial fibrillation in Thailand (COOL AF Thailand)

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Cervical Cancer Screening and Prevention in Latinas. Sandra Torrente, MD, MSc Kenneth Grullon, MD

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology

FACT SHEET. Women in Treatment

Antithrombotic Therapy in Patients with Atrial Fibrillation

Modifiable Up-Stream Risk Factors:

Devices to Protect Against Stroke in Atrial Fibrillation

Patent Foramen Ovale: Diagnosis and Treatment

IS THERE STILL A PLACE FOR VITAMINE K ANTAGONISTS?

Chapter 3: Morbidity and Mortality

Management of new onset atrial fibrillation McNamara R L, Bass E B, Miller M R, Segal J B, Goodman S N, Kim N L, Robinson K A, Powe N R

Prevalence of Atrial Fibrillation in China and Its Risk Factors *

Defining Sub-Clinical Atrial Fibrillation and its management

Incident atrial fibrillation in relation to disability-free survival, risk of fracture, and

MATERNAL AND CHILD HEALTH AND DISPARITIES FOR ASIAN AMERICANS, NATIVE HAWAIIANS, AND PACIFIC ISLANDERS

NUOVI ANTICOAGULANTI NELL ANZIANO: indicazioni e controindicazioni. Mario Cavazza Medicina d Urgenza Pronto Soccorso AOU di Bologna

Transcription:

ATRIAL FIBRILLATION AND ETHNICITY Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)

Atrial fibrillation (AF) and ethnicity The known The unknown The paradox

Why AF is important AF is the most common sustained arrhythmia in clinical practice Over 2.3 million adults in the US have AF, and the number is expected to more than 10 million in 2050 The lifetime risk of developing AF is approximately 1 in 4 AF rates increase with advancing age, making AF a more relevant challenge as the population ages 35% of all hospital admissions for arrhythmia are attributable to AF

Why AF is important AF has a considerable impact on cardiovascular morbidity and mortality One of every 6 strokes occurs in patients with AF The rate of ischemic stroke among patients with AF is about 5% per year; 2 to 7 times higher than that in people without AF AF is independently associated with increased rates of allcause mortality and cardiovascular mortality, and other health outcomes such as heart failure and dementia

Why AF is important AF imposes a substantial cost burden on the healthcare system In 2001, the total annual costs for treatment of AF were estimated at US$6.65 billion 2/3 of all emergency department visits with a primary diagnosis of AF result in hospital admissions During the past 20 years, hospital admissions for AF have increased by 66% 35% of all hospital admissions for arrhythmia are attributable to AF

Key message 1 AF is a major public health problem. Planning and budgeting for future healthcare expenditure imposed by AF require clear understanding of the pathophysiology and epidemiology of AF.

Pathophysiology of AF Benjamin EJ, Chen PS, Bild DE, et al. Circulation 2009

Pathophysiology of AF AF is a complex disease with a multi-factorial etiology that has been investigated mainly in Whites. Many traditional and novel risk factors have been linked to AF, however: It is not clearly understood how these risk factors interact with each other under different genetic predispositions to AF Little is known about the differential impact of these AF risk factors in non-whites vs Whites

Key message 2 A more complete understanding of the pathophysiology of AF requires integration of our knowledge regarding the impact of individual risk factors and their interactions with age, sex and race in the context of different genetic and environmental influences.

Epidemiology of AF in non-whites Few studies addressed the epidemiology of AF in Blacks vs Whites, and fewer extended this to other races

AF in Blacks vs. Whites The Atherosclerosis Risk in Communities (ARIC) Study 15,792 participants (27% Blacks) Age 45-65 years Incident AF detected by ECG, hospital discharge codes, and death certificate from 1987 to 2004 Compared to Whites, Blacks had a 41% risk of AF Incidence rates of AF were 6.7, 4.0, 3.9, and 3.0 per 1,000 persons per year in white men, white women, African-American men, and African- American women, respectively. Soliman EZ, Prineas RJ, Case D, et al. Stroke 2009 Alonso A, Agarwal SK, Soliman EZ, et al. Am Heart J 2009

AF in Blacks vs. Whites The Cardiovascular Health Study (CHS) 5,201 participants (5% Blacks) Age > 65 years Incident AF detected by self-report, ECG and hospital discharge diagnoses from 1989-1993 The AF incidence was lower in Blacks than in Whites (12.0 versus 19.5 per 1000 person-years). Psaty BM, Manolio TA, Kuller LH, et al. Circulation 1997

AF in Blacks vs. Whites The REasons For Geographic And Racial Differences In Stroke (REGARDS) 30,239 participants (42% Blacks) Age>45 years Prevalent AF detected by ECG and self report from 2003-2007 AF was 2-3 times more common in Whites compared to Blacks Meschia JF, Merrill P, Soliman EZ, et al. Stroke 2010

AF in Blacks vs. Whites The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study A cross-sectional study of 1.89 million (4% Blacks) 20 years or older who were enrolled in a large health maintenance organization in California AF was ascertained using hospital and outpatient diagnosis codes and an ECG database. Among persons aged 50 years or older, prevalence of AF was higher in Whites than in Blacks (2.2% vs. 1.5%; P<.001). Go AS, Hylek EM, Phillips KA, et al. JAMA 2001

AF in Blacks vs. Whites The Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study This racial difference in the incidence of AF has been also evidenced in heart failure patients enrolled in EPOCH where Blacks had a 50% lower prevalence of AF than Whites even after adjustment for known risk factors for AF Ruo B, Capra AM, Jensvold NG, et al. J Am Coll Cardiol 2004

AF in Blacks vs. Whites In the US National Hospital Ambulatory Medical Care Survey, rates of visits to an emergency department with AF as the primary diagnosis were higher in Whites than in Blacks (9 vs. 5 per 10,000 person-years) The National Hospital Discharge Survey, which compiles data on discharges from nonfederal hospitals in the United States, also shows a higher incidence of AF hospitalizations in Whites than in Blacks McDonald AJ, Pelletier AJ, Ellinor PT, et al. ANN Emerg Med 2008 Khairallah F, Ezzedine R, Ganz LI, et al. AM J Cardiol 2004

How about other races?

AF in non-blacks non-whites In a meta-analysis of data from 7 randomized clinical trials that prospectively collected information on the development of AF, Asian race was associated with significantly lower rates of AF (odds ratio 0.65, 95% CI 0.50 to 0.84) compared with White race Novaro GM, Asher CR, Bhatt DL, et al. Am J Cardiol 2008

AF in non-blacks non-whites These findings are consistent with a previous report that showed that AF is less common in South Asians newly hospitalized for heart failure compared with Whites (15% vs. 31%, p = 0.0002) Newton JD, Blackledge HM, Squire IB. Heart 2005

AF in non-blacks non-whites In the Northern Manhattan Stroke Study, of those patients presenting with ischemic stroke, AF was more common in Whites (29%) than in either Black (11%) or Hispanic (11%) patient groups Sacco RL, Kargman DE, Zamanillo MC. Neurology 1995

AF in non-blacks non-whites In the West Birmingham AF project, the prevalence of AF was only 0.6% amongst Indo- Asians, who as an ethnic group comprised 65% of the 25,051 general practice population surveyed Lip GYH, Golding DG, Nazir M, et al. British Journal of General Practice

AF in non-blacks non-whites In a large study of 664,754 US Veterans (all males), the prevalence of AF (based on data from hospital discharges and out-patient clinic visits) was 5.7% in Whites, 3.4% in Blacks, 3.0% in Hispanics, 5.4% in native Americans/Alaskans, 3.6% in Asians and 5.2% in Pacific Islanders Borzecki AM, Bridgers DK, Leibsschutz JM, et al. J Nat med Assoc 2008

Key message 3 It seems there is a general agreement that Blacks (and other races) have less AF than Whites...but does this make sense?!

The paradox of AF in Blacks AF risk factors are more common in Blacks compared to Whites, but many studies reported less AF in Blacks!!! Possible explanation? Soliman EZ, Goff Jr DC. J Natl Med Assoc 2008 Soliman EZ, Prineas RJ, Case D, et al. Stroke 2009 Soliman EZ, Alonso A, Goff Jr DC. Future Cardiology 2009

Possible explanation of the paradox of AF in Blacks Limited methodology in previous studies? Differential under-ascertainment of AF in Blacks? Differential impact of AF risk factors in Blacks i.e. Blacks are less affected by AF risk factors? Genetic variants present in Whites but not in Blacks that made Whites more prone to the risk of AF, or genetic variants in Blacks that protect against AF? All of the above? None of the above?

Possible explanation of the paradox of AF in Blacks Limited methodology in previous studies? 12-lead ECG [unlikely to capture paroxysmal AF] Self-report [subjective and prone to errors] Hospital discharge diagnosis [affected by access to health care] Death certificate [unlikely to capture all AF cases] Holter [may be useful but the high cost is an obstacle to use in population studies]

Possible explanation of the paradox of AF in Blacks Limited methodology in previous studies? Limited methodology should result in an under-estimated AF prevalence across races keeping the relative distribution of AF across races intact Soliman EZ, Alonso A, Goff Jr DC. Future Cardiology 2009

Possible explanation of the paradox of AF in Blacks The sensitivity of the method used to detect AF in population studies affects group-specific prevalence estimates: The REGARDS study Prineas RJ, Soliman EZ, Howard G, et al. J Epidemiol 2009

Possible explanation of the paradox of AF in Blacks Limited methodology in previous studies? Limited methodology should result in an overall under-estimated AF prevalence across all races keeping the relative distribution of AF across races intact.unless, there is differential underascertainment of AF in blacks Soliman EZ, Alonso A, Goff Jr DC. Future Cardiology 2009

Possible explanation of the paradox of AF in Blacks Differential under-ascertainment of AF in Blacks? Why a method may disproportionately underdiagnose AF in Blacks more than Whites? It would be appropriate to think that the ability to accurately estimate the incidence/prevalence of AF in any population would be dependent on the proportion of individuals with the difficult-todetect AF patterns such as paroxysmal or asymptomatic AF

Possible explanation of the paradox of AF in Blacks Differential under-ascertainment of AF in Blacks? Is it possible that there is more paroxysmal and/or asymptomatic AF in Blacks that cannot be detected by the AF detection methods used in population studies? No data on the racial differences in AF subtypes No EVIDENCE that Blacks have more paroxysmal AF, but there are CLUES and SPECULATIONS!

More paroxysmal AF in Blacks?? AF risk factors P-wave and PR abnormalities on the ECG (P-wave indices) Paroxysmal AF Chronic (Permanent) AF Soliman EZ, Prineas RJ, Case D, et al. Stroke 2009

More paroxysmal AF in Blacks?? To overcome the limitations of the current approaches of estimating the racial distribution of AF, we suggested using the racial distributions of P-wave abnormalities (P-wave indices) on the ECG as surrogates for racial distribution of future AF in the ARIC study. Our results showed that: Chronic (permanent) AF was significantly less common in Blacks compared with Whites (similar to what has been reported in previous studies) but, Blacks had significantly more abnormal P-wave indices Soliman EZ, Prineas RJ, Case D, et al. Stroke 2009

More paroxysmal AF in Blacks?? With the assumption that the racial distributions of P wave indices could be used as surrogates for the racial distribution of AF (which was confirmed in this study), these results support the contention that Blacks might actually have a higher prevalence of AF that might have been missed by previous studies owing to limited methodology. Speculations?!

More paroxysmal AF in Blacks?? In the REGARDS study, the association between AF and race (Black vs White) was inversely related to the sensitivity of the method used to detect AF; as test sensitivity increased, the association became attenuated. Prineas RJ, Soliman EZ, Howard G, et al. J Epidemiol 2009

More paroxysmal AF in Blacks?? These findings suggest that if a more sensitive approach for AF detection is employed (which will detect more paroxysmal AF), it might result in an estimate showing a reversed distribution of AF, with Blacks having a higher, or at least equal, prevalence of AF, compared to Whites. More speculations?! How about self-reported AF in individual who require regular medical attention (e.g. CKD)? Prineas RJ, Soliman EZ, Howard G, et al. J Epidemiol 2009

More paroxysmal AF in Blacks?? The Chronic Renal Insufficiency Cohort (CRIC) 3,267 participants (50% Blacks) Age 21-74 years AF detected by ECG and self report Results: AF by ECG: Blacks had less AF compared to whites AF by ECG or self-report: Unadjusted and demographic adjusted models: Black had more AF risk [odd ratio and 95% CI: 1.24 (1.04-1.49); and 1.25 (1.03-1.52) respectively] Demographic and clinically adjusted model: No significant difference between Blacks and Whites [1.07 (0.86-1.34)] Soliman EZ, Prineas RJ, Go AS, et al Am Heart J 2010

Possible explanation of the paradox of AF in Blacks Differential impact of AF risk factors in Blacks i.e. Blacks are less affected by AF risk factors? Yes No May be

Possible explanation of the paradox of AF in Blacks Genetic variants present in Whites but not in Blacks that made Whites more prone to the risk of AF, or genetic variants in Blacks that protect against AF? Yes No May be European ancestry is a risk factor for AF in Blacks...but what type of AF; paroxysmal, chronic or both? Marcus GM, Alonso A, Peralta CA et al. Circulation 2010

Possible explanation of the paradox of AF in Blacks Limited methodology in previous studies? Differential under-ascertainment of AF in Blacks? Differential impact of AF risk factors in Blacks i.e. Blacks are less affected by AF risk factors? Genetic variants present in Whites but not in Blacks that made Whites more prone to the risk of AF, or genetic variants in Blacks that protect against AF? All of the above? None of the above? Do not know!!

Key message 4 The less AF in Blacks compared to Whites contradicts with the high rates of AF risk factors in Blacks; the AF paradox in Blacks The inability to explain the paradox of AF in Blacks is complicated by lack of data on the racial distribution of AF subtypes, especially paroxysmal AF Lack of data on the racial distribution of AF subtypes relates mainly to the inherent limitations of the current AF detection methods used in epidemiologic studies

Racial disparities in awareness and treatment of AF In the REGARDS study, Blacks were less likely than Whites to be aware of having AF or to be treated with warfarin: The odds of Blacks being aware of their AF were one third that of whites (odds ratio 0.32; 95% CI: 0.20 to 0.52). Among those aware, the odds of blacks being treated with warfarin were only one fourth as great as whites (odds ratio 0.28; 0.13 to 0.60). Meschia JF, Merrill P, Soliman EZ, et al. Stroke 2010

Concluding remarks We know little about the pathophysiology and epidemiology of AF in non-whites The little we know sometimes contradicts with logic; the paradox of AF in Blacks Our limited knowledge of the epidemiology and pathophysiology of AF in non-whites is an obstacle to effectively address the racial disparities in cardiovascular morbidity and mortality